These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23179449)

  • 1. DNA-hsp65 vaccine as therapeutic strategy to treat experimental chromoblastomycosis caused by Fonsecaea pedrosoi.
    Siqueira IM; Ribeiro AM; Nóbrega YK; Simon KS; Souza AC; Jerônimo MS; Cavalcante Neto FF; Silva CL; Felipe MS; Bocca AL
    Mycopathologia; 2013 Jun; 175(5-6):463-75. PubMed ID: 23179449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early immune response against Fonsecaea pedrosoi requires Dectin-2-mediated Th17 activity, whereas Th1 response, aided by Treg cells, is crucial for fungal clearance in later stage of experimental chromoblastomycosis.
    Siqueira IM; Wüthrich M; Li M; Wang H; Las-Casas LO; de Castro RJA; Klein B; Bocca AL
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008386. PubMed ID: 32542003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
    Romero-Navarrete M; Ruíz LF; Castillo A; Arenas R; Vega-Memije ME; Xicohtencatl-Cortes J; Espinoza-Rivera M; Hernández-Castro R
    J Mycol Med; 2018 Dec; 28(4):663-665. PubMed ID: 30126716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.
    Queiroz-Telles F; Esterre P; Perez-Blanco M; Vitale RG; Salgado CG; Bonifaz A
    Med Mycol; 2009 Feb; 47(1):3-15. PubMed ID: 19085206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.
    Deng S; Lei W; de Hoog GS; Yang L; Vitale RG; Rafati H; Seyedmousavi M; Tolooe A; van der Lee H; Liao W; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of chromoblastomycosis caused by Fonsecaea pedrosoi using imiquimod.
    Belda W; Criado PR; Passero LFD
    J Dermatol; 2020 Apr; 47(4):409-412. PubMed ID: 31960479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
    Le TA; Nguyen KL; Pham MH; Vi TT; Do NA
    Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy.
    Kita Y; Hashimoto S; Nakajima T; Nakatani H; Nishimatsu S; Nishida Y; Kanamaru N; Kaneda Y; Takamori Y; McMurray D; Tan EV; Cang ML; Saunderson P; Dela Cruz EC; Okada M
    Hum Vaccin Immunother; 2013 Mar; 9(3):526-33. PubMed ID: 23249609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
    Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
    Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the antifungal activity of the pyrimidine analogs flucytosine and carmofur against human-pathogenic dematiaceous fungi.
    Coelho RA; Almeida-Silva F; Figueiredo-Carvalho MHG; Rabello VBS; de Souza GR; Lourenço MCDS; Rodrigues ML; Almeida-Paes R
    Med Mycol; 2024 Mar; 62(4):. PubMed ID: 38533658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
    de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
    Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromoblastomycosis due to Fonsecaea monophora in a man with nephritic syndrome.
    Tan H; Xu Y; Lan XM; Wu YG; Zhou CJ; Yang XC
    Mycopathologia; 2015 Jun; 179(5-6):447-52. PubMed ID: 25575792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of IgG immunoglobulin and subclasses level with the severity of chromoblastomycosis due to Fonsecaea pedrosoi and therapeutic response to itraconazole.
    Azevedo CD; Bruña-Romero O; Marques SG; Nascimento FR; Pinto MC; Silva LA; Bouillet LE; Azevedo FS; Stoianoff MA
    Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1791-7. PubMed ID: 24832023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment responses in patients with chromoblastomycosis to itraconazole in Madagascar.
    Sendrasoa FA; Ratovonjanahary VT; Rasamoelina T; Ramarozatovo LS; Rapelanoro Rabenja F
    Med Mycol; 2022 Nov; 60(11):. PubMed ID: 36288247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine.
    Park SG; Oh SH; Suh SB; Lee KH; Chung KY
    Br J Dermatol; 2005 Mar; 152(3):560-4. PubMed ID: 15787829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil.
    Gupta AK; Taborda PR; Sanzovo AD
    Med Mycol; 2002 Oct; 40(5):529-34. PubMed ID: 12462534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.
    Coelho RA; Joffe LS; Alves GM; Figueiredo-Carvalho MHG; Brito-Santos F; Amaral ACF; Rodrigues ML; Almeida-Paes R
    PLoS One; 2020; 15(5):e0229630. PubMed ID: 32401759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the immune response by Fonsecaea pedrosoi morphotypes in the course of experimental chromoblastomycosis and their role on inflammatory response chronicity.
    Siqueira IM; de Castro RJA; Leonhardt LCM; Jerônimo MS; Soares AC; Raiol T; Nishibe C; Almeida N; Tavares AH; Hoffmann C; Bocca AL
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005461. PubMed ID: 28355277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoid combined with photodynamic therapy against hyperkeratotic chromoblastomycosis: A case report and literature review.
    Lan Y; Lu S; Zhang J
    Mycoses; 2021 Jan; 64(1):18-23. PubMed ID: 32989774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
    Yang YP; Li W; Huang WM; Zhou Y; Fan YM
    Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.